Eczema

Immunology·MeSH: Eczema

16 drugs in development·6 companies·15 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
psoria-light	WELLNESS CENTER USA, INC. (WCUI)
Triamcinolone Acetonide and Neomycin Paste	China Health Industries Holdings, Inc. (CHHE)
ZORYVE (roflumilast) cream 0.15%	Arcutis Biotherapeutics, Inc. (ARQT)
ZORYVE (roflumilast) cream 0.3%	Arcutis Biotherapeutics, Inc. (ARQT)
ZORYVE cream (ARQ-151)	Arcutis Biotherapeutics, Inc. (ARQT)

Phase 3(3)

Drug	Company
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)
Roflumilast Cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)
Vehicle Cream	Arcutis Biotherapeutics, Inc. (ARQT)

Phase 2(1)

Drug	Company
ARQ-151 cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)

Phase 1(3)

Drug	Company
ARQ-252	Arcutis Biotherapeutics, Inc. (ARQT)
ARQ-255	Arcutis Biotherapeutics, Inc. (ARQT)
biolexa	Hoth Therapeutics, Inc. (HOTH)

Preclinical(3)

Drug	Company
atopidine	NEUROPATHIX, INC. (TYGS)
leaô	NEUROPATHIX, INC. (TYGS)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)

BLA Filed(1)

Drug	Company
ZORYVE (roflumilast) cream 0.05%	Arcutis Biotherapeutics, Inc. (ARQT)

BioSniper tracks 16 drugs in development for Eczema across 6 companies.

There are 15 clinical trials targeting Eczema tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.